Anaptysbio earnings were -$26.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ANAB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$52.9M, down 206.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ANAB reported annual earnings of -$13.2M, with -90.9% growth. The next ANAB earnings date is Aug 5, 2026.
On ANAB's earnings call on Invalid Date, Anaptysbio (NASDAQ: ANAB) reported Q1 2026 earnings per share (EPS) of -$1.84, up 43.75% year over year. Total ANAB earnings for the quarter were -$52.88 million. In the same quarter last year, Anaptysbio's earnings per share (EPS) was -$1.28.
The next ANAB earnings call is Invalid Date. Add ANAB to your watchlist to be reminded of Anaptysbio's next earnings date.
Is Anaptysbio profitable or losing money?
As of the last Anaptysbio earnings report, Anaptysbio is currently losing money. Anaptysbio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$26.79 million, a 80.95% decrease year over year.
What was ANAB's earnings growth in the past year?
As of Anaptysbio's earnings date in Invalid Date, Anaptysbio's earnings has grown year over year. ANAB earnings in the past year totalled -$26.79 million.
What are Anaptysbio's earnings expectations?
The current EPS estimate for Anaptysbio's earnings report in Invalid Date is $0.39.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.